Amount of grant approval received from National Institutes of Health to support project.

No definition available.

Name:	nuwe_AmountOfGrantApprovalReceived
Namespace Prefix:	nuwe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The amount of non-refundable technology license fee expensed during the period.

No definition available.

Name:	nuwe_NonRefundableTechnologyLicenseFessExpenses
Namespace Prefix:	nuwe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount payable as non-refundable technology license fee in collaboration agreement.

No definition available.

Name:	nuwe_NonRefundableTechnologyLicensePayable
Namespace Prefix:	nuwe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

The number of equal monthly installments to be payable in collaboration agreement.

No definition available.

Name:	nuwe_NumberOfEqualMonthlyInstallment
Namespace Prefix:	nuwe_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

No definition available.

Name:	us-gaap_AssetRetirementObligationAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of discretionary contributions made by an employer to a defined contribution plan.

No definition available.

Name:	us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

No definition available.

Name:	us-gaap_LossContingencyEstimateAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=nuwe_KoronisBiomedicalCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (FY) (Details)		12 Months Ended
Commitments and Contingencies (FY) (Details)	Aug. 05, 2021 USD ($) Installment	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Employee Retirement Plan [Abstract]
Employer's matching contribution		$ 185,000	$ 255,000
Koronis Biomedical Corporation [Member]
Commitments and Contingencies [Abstract]
Amount of grant approval received	$ 1,700,000
Non-refundable technology license fee	$ 428,160
Number of equal monthly installments \| Installment	12
Research and Development Expense [Member] \| Koronis Biomedical Corporation [Member]
Commitments and Contingencies [Abstract]
Non-refundable technology license fee expenses			$ 428,160
Accounts Payable [Member] \| Koronis Biomedical Corporation [Member]
Commitments and Contingencies [Abstract]
Non-refundable technology license fee		$ 178,400